About
Technology
Issues
FAQ
Links
Official Page
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.